Integrated Filing — IndAS
General information about company
| Scrip Code |
533160 |
| NSE Symbol |
DBREALTY |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE879I01012 |
| Name of company |
Valor Estate Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
29-05-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
29-05-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Single segment |
| Description of single segment |
Real Estate |
| Start date and time of board meeting |
29-05-2026 18:30:00 |
| End date and time of board meeting |
29-05-2026 21:15:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
8,691.25 |
1,59,326.93 |
|
Other income |
581.75 |
7,109.96 |
|
Total income |
9,273.00 |
1,66,436.89 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
(6,625.14) |
38,953.33 |
| (b) |
Purchases of stock-in-trade |
0.00 |
0.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(1,348.12) |
69,461.06 |
| (d) |
Employee benefit expense |
471.84 |
2,400.00 |
| (e) |
Finance costs |
2,671.55 |
9,923.49 |
| (f) |
Depreciation, depletion and amortisation expense
|
386.37 |
571.35 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
3,544.34 |
10,244.17 |
| 2 |
Impairment & other credit loss recognition |
17,233.53 |
31,302.20 |
|
Total other expenses |
20,777.87 |
41,546.37 |
|
Total expenses |
16,334.37 |
1,62,855.60 |
| 3 |
Total profit before exceptional items and tax |
(7,061.37) |
3,581.29 |
| 4 |
Exceptional items |
4,478.97 |
6,176.60 |
| 5 |
Total profit before tax |
(2,582.40) |
9,757.89 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
16.20 |
16.20 |
| 8 |
Deferred tax |
(1.14) |
2,568.65 |
| 9 |
Total tax expenses |
15.06 |
2,584.85 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
(2,597.46) |
7,173.04 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
(3,292.89) |
(4,471.57) |
| 16 |
Total profit (loss) for period |
(5,890.35) |
2,701.47 |
| 17 |
Other comprehensive income net of taxes |
(12.71) |
(19.23) |
| 18 |
Total Comprehensive Income for the period |
(5,903.06) |
2,682.24 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
(5,925.20) |
2,547.658 |
|
Total profit or loss, attributable to non-controlling interests |
34.844 |
153.815 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
(12.717) |
(19.227) |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
0.00 |
0.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
54,240.68 |
54,240.68 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
3,54,930.76 |
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
-1.09 |
0.5 |
|
Diluted earnings (loss) per share from continuing operations |
-1.09 |
0.5 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
-1.09 |
0.5 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
-1.09 |
0.5 |
| 24 |
Debt equity ratio |
0.1800 |
0.1800 |
| 25 |
Debt service coverage ratio |
-0.0600 |
0.1600 |
| 26 |
Interest service coverage ratio |
-1.6400 |
1.3600 |
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
7,147.25 |
|
Capital work-in-progress |
0.00 |
|
Investment property |
8,933.62 |
|
Goodwill |
0.00 |
|
Other intangible assets |
0.00 |
|
Intangible assets under development |
|
|
Biological assets other than bearer plants |
|
|
Investments accounted for using equity method |
30,811.14 |
|
Non-current financial assets |
|
|
Non-current investments |
5,436.04 |
|
Trade receivables, non-current |
|
|
Loans, non-current |
77,525.05 |
|
Other non-current financial assets |
|
| 1 |
Other Financial Assets |
2,00,538.83 |
|
Total of other non-current financial assets |
2,00,538.83 |
|
Total non-current financial assets |
2,83,499.92 |
|
Deferred tax assets (net) |
415.64 |
|
Other non-current assets |
|
| 1 |
Income Tax assets |
2,649.47 |
| 2 |
Other Non-Current Assets |
22,792.41 |
|
Total of other non-current assets |
25,441.88 |
|
Total non-current assets |
3,56,249.45 |
| 2 |
Current assets |
|
|
Inventories |
1,45,560.55 |
|
Current financial asset |
|
|
Current investments |
285.55 |
|
Trade receivables, current |
28,155.12 |
|
Cash and cash equivalents |
5,432.13 |
|
Bank balance other than cash and cash equivalents |
2,249.67 |
|
Loans, current |
39,870.09 |
|
Other current financial assets |
|
|
Total of other current financial assets |
40,145.90 |
|
Total current financial assets |
1,16,138.46 |
|
Current tax assets (net) |
|
|
Other current assets |
|
| 1 |
Other current assets |
17,938.47 |
|
Total of other current assets |
17,938.47 |
|
Total current assets |
2,79,637.48 |
| 3 |
Non-current assets classified as held for sale |
|
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
|
|
Total assets |
6,35,886.93 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
54,240.68 |
|
Other equity |
3,54,930.76 |
|
Total equity attributable to owners of parent |
4,09,171.44 |
|
Non controlling interest |
(3,621.30) |
|
Total equity |
4,05,550.14 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
25,597.85 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
17.99 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
302.90 |
|
Total Trade payable |
320.89 |
|
Other non-current financial liabilities |
|
| 1 |
Other Financial Liabilities |
11,399.09 |
|
Total of other non-current financial liabilities |
11,399.09 |
|
Total non-current financial liabilities |
37,317.83 |
|
Provisions, non-current |
623.55 |
|
Deferred tax liabilities (net) |
|
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
|
Total of other non-current liabilities |
|
|
Total non-current liabilities |
37,941.38 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
49,077.57 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
152.85 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
5,095.51 |
|
Total Trade payable |
5,248.36 |
|
Other current financial liabilities |
|
| 1 |
Other Financial Liabilities |
50,124.57 |
|
Total of other current financial liabilities |
50,124.57 |
|
Total current financial liabilities |
1,04,450.50 |
|
Other current liabilities |
63,969.85 |
| 1 |
Other Current Liabilities |
63,969.85 |
|
Total of other current liabilities |
63,969.85 |
|
Provisions, current |
23,975.06 |
|
Current tax liabilities (Net) |
|
|
Deferred government grants, Current |
|
|
Total current liabilities |
1,92,395.41 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
|
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
|
|
Total liabilities |
2,30,336.79 |
|
Total equity and liabilites |
6,35,886.93 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting
period |
31-03-2026 |
31-03-2026 |
| Whether results are audited
or unaudited |
Audited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
null |
null |
|
Net Segment Asset |
null |
null |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
null |
null |
|
Net Segment Liabilities |
null |
null |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
|
Total Amount of items that will not be reclassified to profit and loss |
|
|
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
12.71 |
19.23 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
(12.71) |
(19.23) |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
9,757.89 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
0.00 |
|
Adjustments for decrease (increase) in inventories |
61,416.07 |
|
Adjustments for decrease (increase) in trade receivables, current |
(4,252.87) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
5,355.51 |
|
Adjustments for decrease (increase) in other non-current assets |
(1,375.16) |
|
Adjustments for other financial assets, non-current |
(2,432.49) |
|
Adjustments for other financial assets, current |
(29,237.95) |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(2,809.26) |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
(505.28) |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
571.35 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
31,302.20 |
|
Adjustments for provisions, current |
9,743.97 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
19,831.02 |
|
Adjustments for other financial liabilities, non-current |
(977.54) |
|
Adjustments for unrealised foreign exchange losses gains |
0.00 |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
0.00 |
|
Adjustments for share-based payments |
107.16 |
|
Adjustments for fair value losses (gains) |
(4,625.04) |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
0.00 |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
(310.95) |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
81,800.74 |
|
Net cash flows from (used in)
operations |
91,558.63 |
|
Dividends received |
0.00 |
|
Interest paid |
(9,923.49) |
|
Interest received |
(2,041.28) |
|
Income taxes paid (refund) |
1,682.00 |
|
Other inflows (outflows) of cash |
(3,880.14) |
|
Net cash flows from (used in)
operating activities |
93,878.70 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
0.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
2,556.99 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
0.00 |
|
Purchase of property, plant and equipment |
1,397.83 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
65,514.08 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
623.39 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
30,108.16 |
|
Net cash flows from (used in)
investing activities |
(33,623.37) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
1,512.48 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
306.66 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
21,450.00 |
|
Repayments of borrowings |
70,390.36 |
|
Payments of lease liabilities |
0.00 |
|
Dividends paid |
0.00 |
|
Interest paid |
7,890.58 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
(58,036.76) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
2,218.57 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
0.00 |
|
Net increase (decrease) in cash
and cash equivalents |
2,218.57 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
3,213.57 |
|
Cash and cash equivalents cash
flow statement at end of period |
5,432.14 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
N. A. Shah Associates LLP |
Yes |
31-08-2028 |